Skip to main content
Premium Trial:

Request an Annual Quote

Genome Pharmaceuticals Appoints Six to New Board of Directors

Premium

MUNICH--Genome Pharmaceuticals, a functional genomics company here, has announced a new six-member board of directors. Members include Juergen Drews, president of global research for Hoffmann-La Roche; Ansbert Gaedicke, managing director of Venture Asset Management; Hans Lehrach, director and scientific cofounder of the Max Planck Institute for Molecular Genetics; Helmut Schuehsler, managing partner of TVM Techno Venture Management; Wolfgang Stoiber, managing director of MPM Capital; Ernst-Ludwig Winnacker, director of the Gene Center Munich and president of the Deutsche Forschungsgemeinschaft.

The appointments coincided with a corporate reorganization which, according to Elmar Maier, vice-president of business development, "will provide us with new advantages in Germany, such as equity-based compensation and financing strategies. This will help us attract outstanding individuals to the company and rapidly expand our business." Genome Pharmaceuticals offers an integrated platform of automated high-throughput genomic technologies that includes gene expression analyses, protein interaction mapping, and bioinformatics tools. It plans to collaborate with pharmaceutical companies, offering a combination of three genomic databases.

Filed under

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.